Trial
NCT00256321
Celecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction Carcinoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, Irvine
Collaborators
Sanofi-Synthelabo
Condition
Gastric Carcinoma
Intervention
Oxaliplatin
Why stopped
Closed due to poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-02-08